All news

DiCE Member Codice Viola Helps Shift to Multidisciplinary Pancreatic Cancer Care
DiCE Member Codice Viola Helps Shift to Multidisciplinary Pancreatic Cancer Care
27 April 2022

DiCE Member Codice Viola helps in the shift towards specialised pancreatic cancer care units in the Italian Lombardy Region

...

Read

Promising Research Published for Early Detection of a Certain Pancreatic Cancer
Promising Research Published for Early Detection of a Certain Pancreatic Cancer
26 April 2022

Study published in ‘Gut’ finds new molecular signature that could help in identifying most common form of pancreatic cancer – PDA...

Read

DiCE CRC Biomarkers Project Moves Ahead Thanks to Member Participation
DiCE CRC Biomarkers Project Moves Ahead -Thanks to the Members that Participated!
26 April 2022

Thanks to the help and input of our member organisations the DiCE project for education on CRC biormarkers advances towards delivery

...

Read

DiCE Participates in Global Colorectal Cancer Congress
DiCE Participates in Global Colorectal Cancer Congress
20 April 2022

DiCE CEO Zorana Maravic participates in the 2022 CRC Congress adding the European digestive cancer patient voice to this global event

...

Read

Welcome to Our New Italian Member - Codice Viola
Welcome to Our New Italian Member – Codice Viola
22 March 2022

We are very pleased to give a warm and hearty welcome to Codice Viola into our Digestive Cancers Europe network of Members.

...

Read

Raising Awareness for Rare Cancers - Anal Cancer Awareness Day March 21
Raising Awareness for Rare Cancers – Anal Cancer Awareness Day March 21
18 March 2022

Anal cancer is a rare cancer on the rise. In the EU 9.249 men and women were newly diagnosed with this cancer, in 2020

...

Read

family
March 22 is Lynch Syndrome Awareness Day
18 March 2022

Lynch Syndrome is the most common inherited cancer syndrome in the world, with an estimation of 1 in 370 people carrying the genetic mutation.

...

Read

DiCE Materials Accessible in European Languages
DiCE Materials Accessible in European Languages
18 March 2022

Digestive Cancers Europe Makes Materials Accessible in European Languages

...

Read

EMA recommends approval for nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with advanced oesophageal squamous cell carcinoma (OSCC) with PD-L1 expression
EMA approves two combination-treatments for an aggressive oesophageal cancer
18 March 2022

EMA recommends approval for nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with advanced oesophageal squamous cel...

Read

New Reports Support Improved Cancer Screening Programmes in Europe
New Reports Support Improved Cancer Screening Programmes in Europe
9 March 2022

Two new reports provide recommendations on digestive cancer screening to the European Commission

...

Read

Stay updated about digestive cancer news

Subscribe to our newsletter for updates about our organization, news about our members or medical news about digestive cancers.

Press

For all press inquiries, please drop us a mail.

To the press section

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.